Keywords: sygnis, raises, 2m, euros, via, capital, increase
SYGNIS raises 18.2M euros via capital increase
Article | 17 November 2008
Heidelberg, Germany-based SYGNIS Pharma AG says it that it has raised approximately 18.3 million euros ($23.3 million) through a capital increase. In ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- It's official: "obesity is a disease," says AMA
- Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
